Effect of total flavonoids of Chrysanthemum indicum on TRAIL, TNF-α expression of synovial tissue from adjuvant arthritis rats in vivo

Chinese Pharmacological Bulletin

Volumn 23, Issue 12, 2007, Pages

  Xie, Xue Feng ^a   Li, Jun ^a   Chen, Xiao Yu ^a   Jiang, Hui ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant arthritis; TNF ; Total flavonoids of chrysanthemum indicum (TFC); TRAIL

Indexed keywords

FLAVONOID; FREUND ADJUVANT; GLYCOSIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CHRYSANTHEMUM; CHRYSANTHEMUM INDICUM; CONTROLLED STUDY; DRUG EFFECT; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYNOVIOCYTE; SYNOVIUM; TRIPTERYGIUM;

EID: 38349175107     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Feldmann M, Brennan F M, Maini R N. Rheumatoid arthritis[J]. Cell, 1996,85(3):307-10.
2. Takeda K, Smyth M J, Cretney E, et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development[J]. J Exp Med, 2002,195(2):161-9.
3. Chen W M, Li J, You T P, et al. Anti-inflammatory and immunomodulatory activities of the extracts from the infloresence of Chrysanthemum indicum Linne[J]. Ethnopharm, 2005,101:334-7.
4. Zhang J Y, Zhang L, Li J, et al. The anti-inflammatory effects of total flavonoids of chrysanthemum indicum and its partial mechanism[J]. Acta Univ Med Anhui, 2005,40(5):439-41.
5. Xu S Y, Bian R L, Chen X, ed. Empirical methods of pharmacology [M]. Beijing:People's Medical Publishing House, 1991:723-4.
6. Wang B, Chen M Z, Xu S Y. Separation and cultivation of synovial cells in rats[J]. Chin Pharmacol Bull, 1994,10:73-4.
7. Xia L J, Chen F H, Ren B, et al. Effect of recombinant human endostatin on proliferation and cytokines production of synoviocytes from adjuvant arthritis rats in vivo[J]. Chin Pharmacol Bull, 2007, 23(1):59-63.
8. Firestein G S, Yeo M, Zvaifler N J. Apoptosis in rheumatoid arthritis synovium[J]. J Clin Invest, 1995,96(3):1631-8.
9. Wiley S R, Schooley K, Smolak P J, et al. Identification and characterization of new member of the TNF family that induces apoptosis[J]. Immunity, 1995,3(6):673-82.
10. Fang F, Wang A P. Advancement on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its induced apoptosis mechanism of tumor cell[J]. Foreign Med Sci Sect Pharm, 2005,32(1):6-10.
11. Fassbender H G. The disease picture in rheumatoid arthritis as a result of different pathomechanisms[J]. Z Rheumatol, 1985,44(1):33-44.
12. Song K, Chen Y, Göke R, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression[J]. J Exp Med, 2000,191(7):1095-104.
13. Yao Q, Seol D W, Mi Z, et al. Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis[J]. Arthritis Res Ther, 2006,8 (1):R16 (doi:10.1186/ar1867).
14. Lunemann J D, Waiczies S, Ehrlich S, et al. Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (auto) antigen-Specific T Cells[J]. J Immunol, 2002,168(10):4881-8.
15. Gravallese E M, Pettit A R, Lee R, et al. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumor necrosis factor alpha[J]. Ann Rheum Dis, 2003,62(2):100-7.
16. Hessian P A, Highton J, Kean A, et al. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma[J]. Arthritis Rheum, 2003,48(2):334-48.